HomeNewsBusinessContract staffing demand for tech talent nears pre-COVID levels

Contract staffing demand for tech talent nears pre-COVID levels

While pent-up demand is being cited as a reason for the surge in contract staffing, a healthy deal pipeline at IT firms is also driving the need for manpower.

December 17, 2020 / 17:02 IST
Story continues below Advertisement

After a largely dismal year, things seem to be finally looking up for contract staffing firms catering to the IT sector. After having witnessed a steep decline due to the pandemic since April, demand is now back to 80-90 percent of pre-COVID-19 levels. Also, salary increases of up to 20 percent are on offer for niche talent.

“Never seen a December as bullish as this year,” said Sanju Ballurkar, President of Experius IT, a part of staffing firm ManpowerGroup India.

Story continues below Advertisement

December is a seasonally weak quarter for IT firms and demand is usually sluggish in this period. Now, with demand recovering and IT firms having better visibility for the next few months, contract firms like ManpowerGroup are now seeing a surge in demand.

According to a 2017 report by the Indian Staffing Federation, flexi-staffing in IT accounted for about 2.6 lakh of the total Indian IT workforce. The IT industry currently employs close to 45 lakh people.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show